chigio70
Nuovo Utente
- Registrato
- 28/12/08
- Messaggi
- 1.508
- Punti reazioni
- 42
Buon anno ...abbiamo molta strada da percorrere, se la news di ieri sarà suffragata da fatti concreti, il futuro di Gnbt sarà più che roseo....
Buon Anno a Tutti Voi
Concordo pienamente, se arriveranno conferme, la vedo MOLTO bene,.,. Tanta Roba
Generex and NuGenerex Immuno-Oncology Provide Update on Ii-Key COVID-19 Vaccine Development Program and Files Trademark Application for The Complete Vaccine™
•The trademark application can be found at USPTO.gov by searching “Complete Vaccine” in the Trademark Electronic Search System (TESS)
•Ii-Key-SARS-CoV-2 vaccine enters GMP production for clinical supply
•Ii-Key epitopes selected that elicit both CD4+ T Helper cell (Th1) and CD8+ responses that are necessary for long-term immune memory
•Ii-Key epitopes elicited no Th2 T cell responses that have been linked to antibody dependent enhancement of disease and cytokine storm
•Ii-Key epitopes have been used to purify Anti-SARS-CoV-2 antibodies from convalescent COVID-19 patient serum
•Neutralizing antibodies purified with Ii-Key epitopes have potential as a therapeutic treatment for COVID-19
•Addressing emergence of mutant coronavirus strains
•Exploring new opportunities to utilize Ii-Key-SARS-CoV-2 vaccines as a targeted universal booster designed to alleviate the immune related side effects reported with the current RNA vaccines
Questo ultimo punto potrebbe aprire scenari impensabili,.,.
Credo che la scelta, probabilmente obbligata, di passare dalla Cina sia vincente, perché in questo modo evitiamo il "tappo" delle Big Pharma